Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Dufek

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Parkinson'S Disease|September 10, 2015
Interleukin-6 May Contribute to Mortality in Parkinson's Disease Patients: A 4-Year Prospective StudyMichal Dufek, Irena Rektorova, Vojtech Thon, et al.
Acta Neurologica Belgica|April 18, 2008
Recurrent miller fisher syndrome with abnormal terminal axon dysfunction: a case reportJan Tomcík, Michal Dufek, Jan Hromada, et al.
Parkinsonism & Related Disorders|April 12, 2008
Vascular pathology in patients with idiopathic Parkinson's diseaseIvan Rektor, David Goldemund, Katerina Sheardová, et al.
Brain and Behavior|July 27, 2018
Obstetric anesthesia/analgesia does not affect disease course in multiple sclerosis: 10-year retrospective cohort studyHana Harazim, Pavel Štourač, Petr Janků, et al.
Frontiers in Neurology|June 6, 2019
Impaired Self-Other Distinction and Subcortical Gray-Matter Alterations Characterize Socio-Cognitive Disturbances in Multiple SclerosisKristína Czekóová, Daniel Joel Shaw, Kristína Saxunová, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2012
Impairment of brain vessels may contribute to mortality in patients with Parkinson's diseaseIvan Rektor, David Goldemund, Petr Bednařík, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 14, 2018
Interleukin 6 and complement serum level study in Parkinson's diseaseBranislav Veselý, Michal Dufek, Vojtech Thon, et al.
Frontiers in Neuroscience|October 1, 2021
Alterations in Sensorimotor and Mesiotemporal Cortices and Diffuse White Matter Changes in Primary Progressive Multiple Sclerosis Detected by Adiabatic RelaxometryPavel Filip, Michal Dufek, Silvia Mangia, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Relationship between Patient Preferences, Attitudes to Treatment, Adherence, and Quality of Life in New Users of TeriflunomideDaniela Štrosová, Jan Tužil, Barbora Velacková Turková, et al.
Journal of Neurology|June 29, 2026
Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS studyRiley Bove, Dawn Langdon, Maciej Maciejowski, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Parkinson'S Disease|September 10, 2015
Interleukin-6 May Contribute to Mortality in Parkinson's Disease Patients: A 4-Year Prospective StudyMichal Dufek, Irena Rektorova, Vojtech Thon, et al.
Acta Neurologica Belgica|April 18, 2008
Recurrent miller fisher syndrome with abnormal terminal axon dysfunction: a case reportJan Tomcík, Michal Dufek, Jan Hromada, et al.
Parkinsonism & Related Disorders|April 12, 2008
Vascular pathology in patients with idiopathic Parkinson's diseaseIvan Rektor, David Goldemund, Katerina Sheardová, et al.
Brain and Behavior|July 27, 2018
Obstetric anesthesia/analgesia does not affect disease course in multiple sclerosis: 10-year retrospective cohort studyHana Harazim, Pavel Štourač, Petr Janků, et al.
Frontiers in Neurology|June 6, 2019
Impaired Self-Other Distinction and Subcortical Gray-Matter Alterations Characterize Socio-Cognitive Disturbances in Multiple SclerosisKristína Czekóová, Daniel Joel Shaw, Kristína Saxunová, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2012
Impairment of brain vessels may contribute to mortality in patients with Parkinson's diseaseIvan Rektor, David Goldemund, Petr Bednařík, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 14, 2018
Interleukin 6 and complement serum level study in Parkinson's diseaseBranislav Veselý, Michal Dufek, Vojtech Thon, et al.
Frontiers in Neuroscience|October 1, 2021
Alterations in Sensorimotor and Mesiotemporal Cortices and Diffuse White Matter Changes in Primary Progressive Multiple Sclerosis Detected by Adiabatic RelaxometryPavel Filip, Michal Dufek, Silvia Mangia, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Relationship between Patient Preferences, Attitudes to Treatment, Adherence, and Quality of Life in New Users of TeriflunomideDaniela Štrosová, Jan Tužil, Barbora Velacková Turková, et al.
Journal of Neurology|June 29, 2026
Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS studyRiley Bove, Dawn Langdon, Maciej Maciejowski, et al.
Pageof 2